Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.

Obstetrics and gynecology - 1 Dec 2002

Ravin Amy J, Edwards Robert P, A Krohn Marijane, Kelley Joseph R, Christopherson Wayne A, Roberts James M

Abstract excerpt

OBJECTIVE: To measure the strength of the association between the factor V Leiden mutation and venous thromboembolism in gynecologic oncology patients. METHODS: We conducted a case-control study of gynecologic cancer patients in a referral center who were group matched for demographics, tumor typ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Factor V
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Postoperative Complications

Share to Reference Values

Share to Risk Assessment

Share to Thromboembolism

Source

Identifiers

PMID: 12468175
DOI: 10.1016/s0029-7844(02)02320-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12468175-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.PMID 12468175Read ↗

Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical PerspectiveSemantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.Semantic proximity Read ↗

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.Semantic proximity Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.Semantic proximity Read ↗

No significant association between the promoter region polymorphisms of factor VII gene and risk of venous thrombosis in cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.